Ostrum Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-1,164
Closed -$147K – 645
2024
Q2
$147K Sell
1,164
-91
-7% -$14.3K 0.01% 539
2024
Q1
$231K Hold
1,255
– – 0.02% 525
2023
Q4
$226K Sell
1,255
-2,393
-66% -$373K 0.02% 513
2023
Q3
$580K Buy
3,648
+2,389
+190% +$391K 0.05% 414
2023
Q2
$178K Buy
1,259
+1
+0.1% +$160 0.01% 541
2023
Q1
$212K Buy
+1,258
New +$224K 0.02% 523

Other funds holding RGEN

Ostrum Asset Management's RGEN Position: Q3 2024 in Review

Ostrum Asset Management sold out of Repligen (RGEN) in Q3 2024, closing a stake of 1,164 shares — an estimated $147K sold.

Ostrum Asset Management first reported a position in RGEN in Q1 2023 and held it in 6 quarters. The position peaked at $580K in Q3 2023. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Ostrum Asset Management reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • Ostrum Asset Management sold 1,164 Repligen shares in Q3 2024, an estimated $147K.
  • Ostrum Asset Management first reported a position in Repligen in Q1 2023 and held it in 6 quarters.
  • Ostrum Asset Management's Repligen position peaked at $580K in Q3 2023.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Ostrum Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.